Immunotherapy with Keytruda (Pembolizumab) in Kyiv typically costs from $3,400 to $6,100. The total price depends on the required number of treatment cycles, medication dosage, and the specific cancer type. In the US, similar treatments cost $17,800 on average. Patients save around 73% in Kyiv. Most clinics include medication, infusion sessions, bloodwork, and follow-up monitoring by an oncologist.
Bookimed Expert Insight: Kyiv serves as Ukraine’s primary hub for high-volume oncology care with massive patient capacities. Large networks like Dobrobut Medical Network treat over 330,000 patients annually and follow strict ISO international standards. This scale allows these institutions to maintain lower operational costs than smaller clinics. Patients can access western-standard protocols at a fraction of the cost found in Germany or Israel.
| Kyiv | Turkey | Austria | |
| Immunotherapy with Keytruda (Pembolizumab) | ≈ $3,400 | from $4,200 | ≈ $5,800 |
No hidden fees – just official clinic prices. Pay at the clinic for Immunotherapy with Keytruda (Pembolizumab) upon arrival and use a flexible installment plan if needed.
Bookimed is committed to your safety. We only work with medical institutions that maintain high international standards in Immunotherapy with Keytruda (Pembolizumab) and have the necessary licenses to serve international patients worldwide.
Bookimed offers free expert assistance. A personal medical coordinator supports you before, during, and after your treatment, solving any issues. You're never alone on your Immunotherapy with Keytruda (Pembolizumab) journey.
Day 1
Day 2
Day 3
Day 4-5
Day 6
Day 7
Weeks 2-4
Please note that each patient"s experience may vary, and you should always follow the advice of your healthcare provider.
Dr. Abu Shamsiya Rami Nuamanovych is a surgical oncologist and gastrointestinal specialist at Dievo Surgery Center. He serves as a consultant for the World Health Organization regarding laparoscopic procedures. Dr. Nuamanovych has performed thousands of surgeries, including bariatric and complex cancer operations. He is the President of the Association of Arab Doctors of Ukraine.
Patients can receive Keytruda immunotherapy at specialized private and public oncology centers in Kyiv. These include Dobrobut Medical Network and Dievo Surgery Center. Treatment requires biomarker confirmation — specifically PD-L1 status or MSI — so doctors know the tumor will respond to this immune checkpoint inhibitor.
Bookimed Expert Insight: While private centers in Kyiv offer infusion services, Dobrobut stands out for its scale — it treats over 330,000 patients annually. Large networks tend to have more stable drug supplies, and that matters because immunotherapy requires consistent dosing every three weeks. Before you travel, always confirm the supply status of pembrolizumab so your cycle is not interrupted.
Patient Consensus: Patients value that Keytruda is often the most accessible immunotherapy drug officially available within Ukraine. Side effects like fatigue or digestive issues do occur. Still, many report that the attentive care in Kyiv centers gives them real confidence.